Effects of Atorvastatin Versus Other Statins on Fasting and Postprandial C-Reactive Protein and Lipoprotein-Associated Phospholipase A2 in Patients With Coronary Heart Disease Versus Control Subjects

This publication has 26 references indexed in Scilit:

• Lipoprotein-Associated Phospholipase A ₂ , High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study
  Circulation, 2004
• Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects
  The American Journal of Cardiology, 2004
• Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study
  Circulation, 2003
• Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
  New England Journal of Medicine, 2002
• Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects
  The American Journal of Cardiology, 2002
• Comparison of fasting and postprandial plasma lipoproteins in subjects with and without coronary heart disease
  The American Journal of Cardiology, 2001
• Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner
  Atherosclerosis, 2001
• Lipoprotein-Associated Phospholipase A₂as an Independent Predictor of Coronary Heart Disease
  New England Journal of Medicine, 2000
• Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study.
  Circulation, 1993
• Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1987